Rose Brophy

Nov 25, 2024 | uschamber.com | Brad Watts |Rose Brophy

Each year, the U.S. Chamber of Commerce celebrates leaders who rely on IP protection to advance cultural, scientific, and technological solutions to the world’s leading challenges. The Chamber's Global IP Champions event recognizes those who constantly demonstrate leadership, ingenuity, and creativity in pursuing strong intellectual property rights and brings together the visionaries in innovation and creativity who create jobs, underpin economic growth, and enhance our shared competitiveness.

Sep 23, 2024 | uschamber.com | Brad Watts |Rose Brophy

Download September 23, 2024 Dear Chairman Sanders:  I write on behalf of the U.S. Chamber of Commerce (“Chamber”) to express our deep concern about your apparent approach to the upcoming hearing entitled “Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?” As the title of the hearing itself indicates, along with your many previous public statements, this isn’t an exercise in fact-finding.

Sep 16, 2024 | uschamber.com | Brad Watts |Rose Brophy |Jordan Crenshaw

Experts agree that quantum computing holds the key to the next generation of breakthroughs across critical sectors like healthcare, green tech, supply chain optimization, and machine learning. With the potential to become a $1.3 trillion industry by 2035, it's no surprise that the U.S. government is keen on exploring this realm. However, for quantum computing to reach its full potential, a collaborative partnership between the public and private sectors is essential.

Aug 15, 2024 | uschamber.com | Rose Brophy |Brad Watts

Today’s White House announcement effectively sets the price for 10 lifesaving medicines. While the Biden Administration claims this will benefit American patients, they overlook the significant issues with price controls. The Chamber’s research has demonstrated that because of price controls and other market-restrictive policies American patients will have reduced access to new cures and treatments and face longer wait times for existing medicines.

Aug 15, 2024 | uschamber.com | Rose Brophy |Brad Watts

WASHINGTON, D.C. — Tom Quaadman, Executive Vice President of the Global Innovation Policy Center at the U.S. Chamber of Commerce, released the below statement on the Biden Administration's announcement of the results of the so-called negotiation for a selected set of prescription drugs: "The U.S. Chamber supports access to affordable medicine, but today's announcement is the result of government-set price controls, not a true negotiation. Under this approach, patients lose.